NCT06626412View on ClinicalTrials.gov

Longitudinal SV2A and MRI in Premanifest HD

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Huntington Disease
Interventions
DIAGNOSTIC_TEST

Diagnostic Test: 18F-SynVesT-1 PET

Positron Emission Tomography (PET) of synaptic vesicle protein 2A (SV2A) using the radioligand 18F-SynVesT-1.

DIAGNOSTIC_TEST

Volumetric MRI

Magnetic resonance imaging of brain volume.

Trial Locations (1)

3000

RECRUITING

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER